vimarsana.com

Page 22 - Dynavax Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Biodefense Market Revenue Will Attain US$24 5 Bn by

Fisher Asset Management LLC Sells 134,346 Shares of Dynavax Technologies Co (NASDAQ:DVAX)

Fisher Asset Management LLC trimmed its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Get Rating) by 3.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,083,689 shares of the biopharmaceutical company’s stock after selling 134,346 shares during the quarter. Fisher […]

Wealth Effects LLC Cuts Stock Position in Dynavax Technologies Co (NASDAQ:DVAX)

Wealth Effects LLC decreased its position in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Get Rating) by 38.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,750 shares of the biopharmaceutical company’s stock after selling 17,500 shares during […]

Wedbush Securities Inc Sells 2,000 Shares of Dynavax Technologies Co (NASDAQ:DVAX)

Wedbush Securities Inc. cut its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Get Rating) by 10.3% in the fourth quarter, HoldingsChannel reports. The fund owned 17,500 shares of the biopharmaceutical company’s stock after selling 2,000 shares during the period. Wedbush Securities Inc.’s holdings in Dynavax Technologies were worth $186,000 at the end of the most […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.